Introduction
============

Incidence of colonic diverticular hemorrhages is rising due to increasing comorbidities, such as hypertension and arteriosclerosis, and regular use of antiplatelet agents or nonsteroidal anti-inflammatory drugs [@JR219-1] [@JR219-2] [@JR219-3] [@JR219-4] [@JR219-5] [@JR219-6]. Colonic diverticular hemorrhage is the most common cause of lower gastrointestinal bleeding (LGIB) [@JR219-7] [@JR219-8] [@JR219-9], and is seen to resolve spontaneously in 70 % to 90 % of cases [@JR219-7] [@JR219-10] [@JR219-11] [@JR219-12]. However, endoscopic treatment, surgery, or transarterial embolization (TAE) may be required in cases with severe or continuous bleeding [@JR219-12] [@JR219-13] [@JR219-14] [@JR219-15] [@JR219-16].

Colonoscopy is useful for diagnosis of colonic diverticular hemorrhage, and endoscopic treatments for hemostasis include epinephrine injection, contact thermal therapy, and endoscopic clipping (EC) [@JR219-12] [@JR219-17] [@JR219-18] [@JR219-19] [@JR219-20] [@JR219-21] [@JR219-22]. Recently, endoscopic band ligation (EBL) has also been performed to achieve hemostasis [@JR219-23] [@JR219-24] [@JR219-25] [@JR219-26] [@JR219-27] [@JR219-28]. We previously reported that EBL was a safe and effective endoscopic treatment for colonic diverticular hemorrhage, and that resolution of the colonic diverticula may prevent late rebleeding (rebleeding more than 30 days after initial treatment) [@JR219-12] from the banded diverticula [@JR219-28]. However, there are a limited number of reported cases of colonic diverticular hemorrhage treated with EBL, and the long-term outcomes of the procedure have not been elucidated to date. The aim of this study is to investigate the long-term outcomes of EBL and to compare them with those for EC in treatment of colonic diverticular hemorrhage.

Patients and methods
====================

Study population
----------------

This study is a retrospective review of all patients who underwent colonoscopy for diagnosis and treatment of acute LGIB from January 2004 to November 2014 at St. Luke\'s International Hospital in Tokyo. First-line treatment for colonic diverticular hemorrhage was EC from January 2004 to May 2009, and EBL from June 2009 to November 2014. A study flow diagram is presented in [Fig. 1](#FI219-1){ref-type="fig"}.

![ Flowchart of patients with colonic diverticular hemorrhage included in this study.](10-1055-s-0034-1392510-i219ei1){#FI219-1}

Only cases of colonic diverticular hemorrhage were included, and all cases of bleeding (polypectomy bleeding, colorectal cancer, ischemic colitis, vascular ectasia, and ileal diverticular bleeding) were excluded. Presumptive diverticular hemorrhage was ruled out where the stigmata of recent hemorrhage (SRH) were absent in the colonoscopy, because it is essential for unequivocal identification of specific diverticula as the bleeding source. Sources were classified, using colonoscopy, into active bleeding (AB), non-bleeding visible vessel (NBVV), or adherent clots (AC) [@JR219-12]. A total of 163 patients were diagnosed with definite colonic diverticular hemorrhage with SRH. Patients treated with TAE, surgery, or epinephrine injection therapy as first-line therapy were excluded. A total of 154 patients with definite diverticular hemorrhage were successfully treated with EBL or EC as first-line treatment. Patients who were followed up for less than 1 year after initial endoscopic treatments (EBL or EC) at St. Luke\'s International Hospital were excluded, resulting in a final sample of 61 patients in the EBL group and 39 patients in the EC group. 

Treatment methods
-----------------

Colonoscopy was performed after bowel preparation with polyethylene glycol, in both the EBL and the EC groups. However, patients with hemodynamic instability did not undergo bowel preparation. Endoscopic treatments were performed by well-trained endoscopists and a trainee under the supervision of experts.

The EBL method was performed as follows ([Fig. 2](#FI219-2){ref-type="fig"}) [@JR219-25] [@JR219-26] [@JR219-27] [@JR219-28]: Once the diverticula were identified with SRH, they were marked with hemoclips and the endoscope was removed. It was then reinserted after a band-ligator device (MD-48710 EVL Device, Sumitomo Bakelite Co., Tokyo, Japan) was attached to its tip. When the endoscope head reached the target point, the bleeding diverticula were suctioned into the band-ligator cup. Thereafter, the O-band was released to ligate the inverted diverticula. Tattooing was not performed at the bleeding point. If EBL was not successful, other endoscopic treatments, such as endoscopic clipping or epinephrine injection therapy, were performed.

![Endoscopic band ligation (EBL) for colonic diverticular hemorrhage. Endoscopic view of the colonic diverticulum with active bleeding. **b** Marking with hemoclips was performed near the diverticulum.**c**The elastic O-ring was released and a visible vessel was observed on the banded diverticulum.](10-1055-s-0034-1392510-i219ei2){#FI219-2}

EC was performed as previously reported ([Fig. 3](#FI219-3){ref-type="fig"}) [@JR219-22], i. e., by direct placement of hemoclips (HX-600-090 L, HX-600-135, HX-610-090 L, or HX-610-135; Olympus Medical Systems, Tokyo, Japan), if feasible, on the targeted vessel. When direct placement was considered difficult because of the dome location or massive hemorrhage, indirect placement (closing with multiple hemoclips in a zipper fashion) was performed.

![Endoscopic clipping (EC) for colonic diverticular hemorrhage. Direct placement of hemoclips on the targeted vessel was performed. **b** Indirect placement of hemoclips was performed in a zipper fashion.](10-1055-s-0034-1392510-i219ei3){#FI219-3}

Follow-up after endoscopic treatments
-------------------------------------

After endoscopic treatment, patients were followed up on an outpatient basis at St. Luke\'s International Hospital. Continuous massive hematochezia after endoscopic treatments was considered as rebleeding. In such situations, a repeat colonoscopy was performed to retreat the diverticula, or to rule out other bleeding lesions, such as colonic neoplasms or vascular ectasia. If required, additional treatments were administered based on the judgment of the attending gastroenterologists.

In the EBL group, follow-up colonoscopy was performed after the procedure to confirm the disappearance of the banded diverticula, except in patients with severe comorbid conditions such as cardiovascular disease. A convergence of folds at the site of the previously banded diverticula, seen on follow-up colonoscopy, was considered as the disappearance of the diverticula with SRH ([Fig. 4](#FI219-4){ref-type="fig"}) [@JR219-28]. However, the presence or absence of the previously banded diverticula could not be confirmed in all cases because tattooing was not performed near the bleeding point. In such cases, we recorded the results as unknown. This study was approved by the ethics committee of our hospital, and written informed consent was obtained from all patients. The patients who were not followed up at St. Luke's International Hospital were contacted by telephone to confirm the presence or absence of massive hematochezia after endoscopic treatments.

![Scar formation was observed at the previously banded site in a follow-up colonoscopy.](10-1055-s-0034-1392510-i219ei4){#FI219-4}

Statistical analysis
--------------------

Statistical analysis was performed using JMP version 9 (SAS Institute Inc., USA). Patients\' ages and follow-up periods after initial treatment were reported as mean \[standard deviation (SD)\] and median (range), respectively. Student\'s t-test or a Mann-Whitney *U*-test were used for continuous variables, and the Fisher\'s exact test was used for categorical variables. A *P*value less than 0.05 was considered statistically significant. Time-to-event analysis of rebleeding was analyzed using the Kaplan-Meier method.

Results
=======

Characteristics of study groups
-------------------------------

The characteristics of patients with definite diverticular hemorrhage treated with EBL or EC are presented in [Table 1](#TB219-1){ref-type="table"}. A statistically significant difference was seen in hypertension comorbidity and median follow-up periods after initial treatments (*P* \< 0.001). No difference was seen, however, in the other parameters. Direct placement of hemoclips was performed in 10 out of 39 patients.

###### Characteristics of patients with definite diverticular hemorrhage treated with endoscopic band ligation (EBL) or endoscopic clipping (EC).

                                               EBL (n = 61)        EC (n = 39)         *P* value
  -------------------------------------------- ------------------- ------------------- ---------------------------------------------
  Male, n (%)                                  44 (72)             29 (74)             0.81
  Age, mean (SD)                               67 (13)             64 (13)             0.32
  Antiplatelet agent, n (%)                    18 (30)             13 (33)             0.69
  NSAIDs, n (%)                                 4 (7)               3 (8)              0.83
  Hypertension, n (%)                          33 (55)             19 (49)              \< 0.001[1](#FN219-1){ref-type="table-fn"}
  Right colon, n (%)                           45 (74)             28( 72)             0.25
  AB : NBVV + AC, n (%)                        25 (41) : 36 (59)   16 (41) : 23 (59)   1.00
  Follow-up periods, median (range) (months)   30 (12 -- 65 )      65 (12 -- 111)       \< 0.001[1](#FN219-1){ref-type="table-fn"}

NSAIDs, non-steroidal anti-inflammatory drugs; AB, active bleeding; NBVV, non-bleeding visible vessel; AC, adherent clot.

A *P*value less than 0.05 was considered statistically significant.

Follow-up profile after initial treatments
------------------------------------------

During the follow-up period, rebleeding occurred in 21 patients from the EBL group and 26 patients from the EC group. It was also seen in 19 of 29 patients treated using indirect placement of EC, and 7 of 10 patients treated with direct placement. Early rebleeding (rebleeding within 30 days after endoscopic treatments) [@JR219-12] occurred in 12 patients in the indirect group and three patients in the direct placement group. The median number of days (range) before occurrence of rebleeding was 92 days (range; 0 -- 934 days) and 874 days (range; 0 -- 1780 days) in the EBL and EC groups, respectively. Management of rebleeding in the EBL group was as follows: conservative therapy, n = 13; EBL, n = 6; EC, n = 1; TAE, n = 0; and surgery, n = 1. Right hemicolectomy was performed in one ascending case, as per the patient\'s preference and not because of uncontrolled bleeding. Management of rebleeding in the EC group was as follows: conservative therapy, n = 8; EBL, n = 2; EC, n = 12; TAE, n = 3; and surgery, n = 1. TAE or surgery was performed because of uncontrolled bleeding in four cases in the EC group.

Long-term outcomes of EBL or EC for diverticular hemorrhage
-----------------------------------------------------------

The Kaplan-Meier test estimates of rebleeding in each group are presented in [Fig. 5](#FI219-5){ref-type="fig"}. In the EBL group, the cumulative incidence of rebleeding at 1, 12, 24, and 36 months were 14 %, 23 %, 26 %, and 41 %, respectively. In the EC group, the cumulative incidence of rebleeding at 1, 12, 24, and 36 months were 38 %, 49 %, 59 %, and 68 %, respectively. The time-to-event analysis revealed statistically significant data (Log-rank test, *P* = 0.0036). A follow-up colonoscopy was performed in 24 out of 61 EBL cases (39 %). Scar formation with fold convergence at the previously banded site, which was considered as complete resolution of the diverticula, was observed in 11 cases (46 %). However, late rebleeding occurred in 5 out of 11 cases.

![ Kaplan-Meier estimates of rebleeding after successful EBL or EC for colonic diverticular hemorrhage.](10-1055-s-0034-1392510-i219ei5){#FI219-5}

Discussion
==========

Recently, endoscopic hemostatic methods such as epinephrine injection, contact thermal therapy, EC, and EBL [@JR219-12] [@JR219-17] [@JR219-18] [@JR219-19] [@JR219-20] [@JR219-21] [@JR219-22] [@JR219-23] [@JR219-24] [@JR219-25] [@JR219-26] [@JR219-27] [@JR219-28] have become the most common treatments for colonic diverticular hemorrhage. In our retrospective cohort study, we investigated long-term follow-up results with EBL and EC for treatment of colonic diverticular hemorrhage.

The walls of the colon are thin, and the absence of a muscular layer in the colonic diverticula implies a risk of perforation during contact thermal therapy and/or epinephrine injection. Therefore, EC is sometimes preferred over contact coagulation therapy for treatment of colonic diverticular hemorrhage, because it provides immediate mechanical hemostasis and causes less injury to the colonic tissues [@JR219-18] [@JR219-19] [@JR219-20] [@JR219-21] [@JR219-22]. However, direct placement of hemoclips on the targeted vessel is difficult, particularly in cases of dome location, massive hemorrhage, or small diverticular orifices [@JR219-20] [@JR219-21] [@JR219-22]. Moreover, the colonic diverticular anatomy sometimes precludes indirect placement of hemoclips at the diverticula for occlusion of either the SRH or the underlying artery [@JR219-29], and bleeding from right-sided diverticulosis (commonly seen in eastern countries) is more severe than that from left-sided diverticulosis [@JR219-30]. High rates of rebleeding after EC were seen in the current study in which 29 patients (74 %) were treated using the indirect method and 28 bleeding diverticula (72 %) were located in the right colon.

Recently, EBL has been performed to treat colonic diverticular hemorrhage with the band-ligator device that is widely used for esophageal varices [@JR219-25] [@JR219-26] [@JR219-27] [@JR219-28]. In the current study, the rate of rebleeding was significantly lower in the EBL group than in the EC group. By occluding SRH and underlying arteries using EBL, higher hemostatic effects and lower rebleeding rates may be obtained, and late bleeding from the "same" diverticula could be prevented by resolution of the banded diverticula.

However, late rebleeding occurred in five cases where the follow-up colonoscopy showed resolution of the banded diverticula. These results imply that late rebleeding occurred from different diverticula, implying that it cannot be prevented even after resolution of the previously banded diverticula.

The main limitation of this study was the difference in the follow-up periods between the EBL and EC groups. In our institution, until May 2009, colonic diverticular hemorrhage had been treated mainly with EC; in June 2009, it was replaced by EBL. Therefore, rebleeding after initial treatments were compared between the groups using the Kaplan-Meier method.

In conclusion, although the current study was retrospective and the number of patients followed up long term was limited, EBL was considered superior to EC in treatment of colonic diverticular hemorrhage. However, the risk of rebleeding could not be avoided, even after resolution of the diverticula using EBL.
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